HISTOPATHOLOGICAL SPECTRUM OF RENAL LESIONS IN POST NEPHRECTOMY SPECIMENS: AN AUDIT IN BURDWAN MEDICAL COLLEGE AND HOSPITAL.

Main Article Content

Dr Susanta Kumar Das,
Dr. Koushik Bose,
Dr. Anushila Roy,

Keywords

.................

Abstract

: Nephrectomy is a surgical procedure for certain renal pathologies that include a wide spectrum of non-neoplastic and neoplastic entities, ranging from inflammatory conditions like pyelonephritis to malignant neoplasms such as renal cell carcinoma (RCC). Histopathological examination is the gold standard for definitive diagnosis and classification.


Aims and Objectives: To study the clinicopathological profile of renal lesions over a six-year period in a tertiary care hospital in West Bengal Methods: This was a hospital based retrospective descriptive study conducted over six years, including 65 nephrectomy specimens. Clinical data, gross morphology, and histopathological specimens were reviewed. The lesions were categorized into non-neoplastic (inflammatory and degenerative) and neoplastic groups (benign and malignant).


Results: Among 65 renal specimens analyzed, 38 cases (58.5%) were neoplastic and 27 cases (41.5%) were non-neoplastic. The neoplastic category was dominated by renal cell carcinoma (RCC), comprising 34 cases (52.3%), of which clear cell RCC accounted for 25 cases (73.5%), papillary RCC for 5 cases (14.7%), and chromophobe RCC for 4 cases (11.8%). Non-neoplastic lesions included chronic pyelonephritis (14 cases), hydronephrosis (6 cases), xanthogranulomatous pyelonephritis (3 cases), and advanced chronic kidney disease-related changes (4 cases). The age range of patients was 25–80 years, with a mean age of 52.4 years. Males predominated with a male-to-female ratio of 1.4:1. The left kidney was slightly more involved (56.9%) than the right (43.1%). Most RCC cases presented at stage pT1–pT2, with Fuhrman Grade 2 being most frequent.


Conclusion: This study provides a detailed histopathological spectrum of nephrectomies performed at our institution hence provides a reflection of the clinical spectrum in this part of the country. Non-neoplastic inflammatory lesions continue to form a significant proportion of renal pathology. However, renal cell carcinoma, particularly the clear cell subtype, remains the most common malignant lesion. Histopathological evaluation is crucial for accurate diagnosis, subclassification, and grading, directly influencing management and prognosis. In developing countries benign diseases are more common than malignancies.

Abstract 52 | Pdf Downloads 12

References

. Moch H, et al. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 5th ed. Lyon: IARC; 2022.
2. Rao RN, et al. Clinicopathological spectrum of renal cell carcinoma: A tertiary care experience. Indian J Pathol Microbiol. 2019;62(3):415–420.
3. Deshmukh SD, et al. Histopathological study of renal lesions in nephrectomy specimens. J Clin Diagn Res. 2020;14(5):EC05–EC09.
4. Van Poppel H, et al. Nephron-sparing surgery for renal cell carcinoma: an overview. Nat Rev Urol. 2011;8(7):396–405.
5. Campbell SC, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2017;198(3):520–529.
6. Bonsib SM. The classification of renal tumors: update and challenges. Histopathology. 2020;76(1):25–36.
7. Prasad K, et al. Non-neoplastic renal lesions in nephrectomy specimens: A clinicopathological analysis. Indian J Med Res. 2021;153(2):142–148.
8. Bhuyan C, et al. Nonneoplastic lesions in nephrectomy specimens: A histopathological spectrum. Ann Pathol Lab Med. 2018;5(9):A806–A810.
9. Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894–906.
10. Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality. CA Cancer J Clin. 2021;71(3):209–249.
11. Dagher J, et al. Clear cell renal cell carcinoma: molecular characterization and clinical management. J Clin Oncol. 2018;36(36):3574–3582.
12. Akhtar M, et al. Chromophobe renal cell carcinoma: clinicopathologic and molecular features. Adv Anat Pathol. 2020;27(3):177–186.
13. Singh R, et al. Spectrum of renal lesions in nephrectomy specimens: A tertiary care experience. J Evol Med Dent Sci. 2018;7(17):2091–2095.
14. Liss MA, et al. Epidemiology of kidney cancer: trends and disparities. Curr Opin Urol. 2020;30(4):237–241.
15. Delahunt B, et al. Grading of clear cell renal cell carcinoma. Histopathology. 2019;74(1):4–17.
16. Netto GJ, et al. Diagnostic utility of immunohistochemistry in renal neoplasms. Arch Pathol Lab Med. 2020;144(4):386–400.
17. Ljungberg B, et al. EAU Guidelines on Renal Cell Carcinoma 2023. Eur Urol. 2023;83(2):134–151.